Study on the anti-hepatitis mechanism of Abrus pulchellus subsp. cantoniensis (Hance) Verdc. and Abrus pulchellus subsp. mollis (Hance) Verdc. based on serum pharmacochemistry and network pharmacology
|更新时间:2025-11-25
|
Study on the anti-hepatitis mechanism of Abrus pulchellus subsp. cantoniensis (Hance) Verdc. and Abrus pulchellus subsp. mollis (Hance) Verdc. based on serum pharmacochemistry and network pharmacology
ZHOU Qiaowen,WANG Xue,HUANG Mingjuan,et al.Study on the anti-hepatitis mechanism of Abrus pulchellus subsp. cantoniensis (Hance) Verdc. and Abrus pulchellus subsp. mollis (Hance) Verdc. based on serum pharmacochemistry and network pharmacology[J].ZHONGGUO YAOFANG,2025,36(22):2772-2777.
ZHOU Qiaowen,WANG Xue,HUANG Mingjuan,et al.Study on the anti-hepatitis mechanism of Abrus pulchellus subsp. cantoniensis (Hance) Verdc. and Abrus pulchellus subsp. mollis (Hance) Verdc. based on serum pharmacochemistry and network pharmacology[J].ZHONGGUO YAOFANG,2025,36(22):2772-2777. DOI: 10.6039/j.issn.1001-0408.2025.22.04.
Study on the anti-hepatitis mechanism of Abrus pulchellus subsp. cantoniensis (Hance) Verdc. and Abrus pulchellus subsp. mollis (Hance) Verdc. based on serum pharmacochemistry and network pharmacology
SD rats were randomly divided into blank group, AC-treated group, and AM-treated group, with each group consisting of 10 rats. The rats’ orbital venous blood was collected at 5, 15, 30 minutes, and 1, 1.5, 2, 4, 6, 8, 12 hours after gavage administration of 24 g/kg of the corresponding drug (calculated by crude drug) or water, respectively. Ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry technology was utilized to identify the prototype components present in the serum. The network pharmacology method was adopted to predict the anti-hepatitis active components, key targets, and signaling pathways of AC and AM. Additionally, molecular docking technology was utilized to verify the binding activity of the core active components with key targets.
RESULTS
2
A total of 35 prototype components migrating to the blood of AC and AM were identified in the serum of administered rats, among which 24 were common components. The active components in AC, such as acetylanguidine, physcion, soyasaponin A
3
and soyasaponin Ⅰ, as well as those in AM, including vicenin 3, acetylanguidine, soyasaponin Ⅰ and schaftoside, all acted on key targets such as steroid receptor coactivator, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, epidermal growth factor receptor (EGFR), and protein kinase B1 (Akt1). These components modulated pathways in cancer, EGFR tyrosine kinase inhibitor resistance, and the phosphoinositide 3-kinase (PI3K)-Akt pathway, thereby exerting anti-hepatitis effects. Furthermore, the binding energies between these active components and their key targets were all less than -5 kJ/mol.
CONCLUSIONS
2
There are differences in the active components of AC and AM against hepatitis, but their mechanisms of action are similar. Both may exert their anti-hepatitis effects through pathways in cancer, EGFR tyrosine kinase inhibitor resistance, and the PI3K-Akt pathway.
ZAKRZEWSKA S , NIXON S A , CHEN Z , et al . Structural basis for saxitoxin congener binding and neutralization by anuran saxiphilins [J ] . Nat Commun , 2025 , 16 ( 1 ): 3885 .
YAM-PUC A , ESCALANTE-EROSA F , PECH-LÓPEZ M , et al . Trinorsesquiterpenoids from the root extract of Pentalinon andrieuxii [J ] . J Nat Prod , 2009 , 72 ( 4 ): 745 - 748 .
ONO M , ITO Y , ISHIKAWA T , et al . Five new monoterpene glycosides and other compounds from foeniculi fructus(fruit of Foeniculum vulgare Miller) [J ] . Chem Pharm Bull , 1996 , 44 ( 2 ): 337 - 342 .
NILIUS B , PRENEN J , OWSIANIK G . Irritating channels:the case of TRPA1 [J ] . J Physiol , 2011 , 589 ( Pt 7 ): 1543 - 1549 .
HOANG D M , NGOC T M , DAT N T , et al . Protein tyrosine phosphatase 1B inhibitors isolated from Morus bombycis [J ] . Bioorg Med Chem Lett , 2009 , 19 ( 23 ): 6759 - 6761 .
WANG X , HUANG M J , LU Y X , et al . Integrated metabolomics and network pharmacology reveal the PI3K/Akt-mediated therape utic mechanism of Abrus cantoniensis in lipid metabolism disorders [J ] . Phytomedicine , 2025 , 145 : 156953 .
LI Y , FENG J X , GUO X D , et al . Efficacy and safety of finerenone in non-diabetic CKD patients:a single-center,real-world,retrospective study [J ] . BMC Nephrol , 2025 , 26 ( 1 ): 323 .
DING J , JI J , RABOW Z , et al . A metabolome atlas of the aging mouse brain [J ] . Nat Commun , 2021 , 12 ( 1 ): 6021 .
DU K C , LI X Y , ZHENG C W , et al . Three undescribed flavonoids and amide from Abrus mollis Hance with hepatoprotective effects [J ] . Chem Biodivers , 2023 , 20 ( 7 ): e202300696 .
CHEN Y Y , YAN X J , JIANG X H , et al . Vicenin 3 ameliorates ECM degradation by regulating the MAPK pathway in SW1353 chondrocytes [J ] . Exp Ther Med , 2021 , 22 ( 6 ): 1461 .
CHOI Y J , SHIN H W , CHUN Y S , et al . Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1 [J ] . Oncotarget , 2016 , 7 ( 38 ): 62107 - 62122 .
SEO H Y , LEE S H , LEE J H , et al . Src inhibition attenuates liver fibrosis by preventing hepatic stellate cell activation and decreasing connetive tissue growth factor [J ] . Cells , 2020 , 9 ( 3 ): 558 .
SCHRADER J A , BURKARD T L , BRÜGGEMANN Y , et al . EGF receptor modulates HEV entry in human hepatocytes [J ] . Hepatology , 2023 , 77 ( 6 ): 2104 - 2117 .
WANG S H , HUANG Z , LEI Y , et al . Celastrol alleviates autoimmune hepatitis through the PI3K/AKT signaling pathway based on network pharmacology and experiments [J ] . Front Pharmacol , 2022 , 13 : 816350 .